Patients presenting to the emergency department with presumed opioid overdoses show a low rate of delayed intubation.

SAN DIEGO -- Two retrospective studies hinted at potential negative effects of GLP-1 receptor agonists for patients requiring ...

However, there are also significant benefits to the scientific clinical trial process that allows synthetic drugs to be systematically tested and used to treat illnesses that natural medicine ...

Less than a year after cutting coverage of GLP-1 weight loss drugs such as Wegovy, the North Carolina State Health Plan is now asking the legislature to pay for bringing back coverage. The North ...

A federal court in Texas has rejected a request by producers of compounded drugs to extend their ability to manufacture knockoff versions of Eli Lilly's tirzepatide while a lawsuit plays out.

A market has announced it is closing due to "out of control drinking, drug use, and violence". Littlehampton's weekly Friday market said it will close on March 28, citing an unsafe environment on ...

CHAMBERS. NEW AT FOUR. FLORIDA’S INSURANCE REGULATOR IS DEMANDING DETAILED PRESCRIPTION DRUG DATA ON MILLIONS OF PATIENTS. THE REQUEST IS RAISING CONCERNS ABOUT PATIENT PRIVACY AND GOVERNMENT ...

The Ohio Department of Health can’t take action against a website offering information about abortion drugs via telehealth, according to that agency’s response to a complaint filed by Ohio ...

He chose to become *** major drug trafficker and he chose to become *** killer. They were one of the largest suppliers of cocaine to Canada and into the United States. They moved on average 60 ...

Prescription drugs undergo two naming processes: one for the generic (nonproprietary) version and one for the brand (proprietary) name. Generic names are assigned by international organizations ...

Dozens of people have been arrested during a major crackdown on organised criminal gangs and drug supply networks in the South West. A number of weapons, including a zombie knife a gun and an ...

Vertex Pharmaceuticals Inc.’s new non-opioid painkiller is being placed on a tier that means it might be costlier than other pain treatments on UnitedHealth Group Inc.’s approved drug lists.